Combination Therapy of Interleukin-12 and Interleukin-2 to Treat Advanced Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00005655
Recruitment Status : Terminated
First Posted : May 5, 2000
Last Update Posted : January 14, 2019
Information provided by:
National Institutes of Health Clinical Center (CC)